Pulmonary Vascular Disease Phenomics Program PVDOMICS
NCT02980887 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1195
Last updated 2025-11-17
Summary
It is recognized that patients with various forms of heart and lung disease exhibit varying degrees of pulmonary hypertension, pulmonary vascular remodeling, and right ventricular dysfunction. The genetic, molecular, and cellular processes driving these phenomena are not well understood. Rapid advances in high throughput omic methodology, combined with powerful bioinformatics and network biology capability, have created the opportunity to conduct studies that broadly search for homologies and differences across the spectrum of disease states associated with pulmonary hypertension, and determinants of the spectrum of right ventricular compensation that accompanies these conditions
Conditions
Interventions
- OTHER
-
No Intervention
There is no intervention in this observational study
Sponsors & Collaborators
-
Brigham and Women's Hospital
collaborator OTHER - collaborator OTHER
-
Weill Medical College of Cornell University
collaborator OTHER - collaborator OTHER
- collaborator OTHER
-
University of Arizona
collaborator OTHER -
Vanderbilt University
collaborator OTHER -
The Cleveland Clinic
lead OTHER
Principal Investigators
-
Nicholas S Hill, MD · Tufts University Medical Center
-
Lei Xiao, MD · National Heart, Lung, and Blood Institute (NHLBI)
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-11-30
- Primary Completion
- 2029-12-31
- Completion
- 2029-12-31
Countries
- United States
Study Locations
More Related Trials
-
Safety Surveillance of Targeted Drugs for Pulmonary Hypertension Using a Computerized Follow-up System: a Nationwide Cohort Study
NCT05372263 ·Status: RECRUITING
-
Bioenergetic Effect of Pioglitazone in CLD-PH
NCT06336798 ·Status: RECRUITING ·Phase: PHASE2
-
Pulmonary Hypertension: Intensification and Personalisation of Combination Rx
NCT05825417 ·Status: RECRUITING ·Phase: PHASE4
-
The PAH Platform for Deep Phenotyping in Korean Subjects
NCT03933579 ·Status: UNKNOWN
-
Safety of SonoVue on Pulmonary Hemodynamics
NCT01306292 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of Endothelin in Pulmonary Hypertension
NCT00759408 ·Status: COMPLETED ·Phase: PHASE2
-
National Registry and Cohort Study of Pulmonary Vascular Disease
NCT05368467 ·Status: RECRUITING
-
Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension
NCT03528902 ·Status: COMPLETED ·Phase: PHASE2
-
Endothelial Function in Patients With Pulmonary Arterial Hypertension
NCT01317134 ·Status: COMPLETED ·Phase: NA
-
Genetic and Environmental Characteristics of Primary Pulmonary Hypertension
NCT00091546 ·Status: COMPLETED
-
Acute Effects of rhBNP in Patients With PH Associated With Acute Exacerbation of Chronic Pulmonary Disease
NCT02742909 ·Status: COMPLETED ·Phase: PHASE4
-
the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension
NCT02061787 ·Status: RECRUITING
-
Targeting Right Ventricle in Pulmonary Hypertension Gilead
NCT02829034 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing
NCT00626028 ·Status: COMPLETED ·Phase: PHASE3
-
Hormonal, Metabolic, and Signaling Interactions in PAH
NCT01884051 ·Status: RECRUITING
-
Endothelial Cell Activation and Total Pulmonary Resistance in PAH
NCT06035861 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
NCT01389206 ·Status: COMPLETED
-
Metabolic Remodeling in Pulmonary Arterial Hypertension (PAH)
NCT04968210 ·Status: COMPLETED
-
Hospital-Based Program for Treatment of Severe Cardiopulmonary Disease With Inhaled Nitric Oxide
NCT00041574 ·Status: TERMINATED ·Phase: PHASE2
-
Telemonitoring to Treat Group 2 Pulmonary Hypertension
NCT04882774 ·Status: WITHDRAWN ·Phase: PHASE2
-
Medication Reconciliation in Pulmonary Hypertension
NCT04744584 ·Status: COMPLETED
-
A Study of Real-world Cohort of Pulmonary Arterial Hypertension (PAH) Participants
NCT04955990 ·Status: TERMINATED ·Phase: PHASE4
-
Dynamic Assessment of Right Ventricular Function With Inhaled Nitric Oxide During Cardiac MRI
NCT02220023 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Trimetazidine in Pulmonary Artery Hypertension
NCT02102672 ·Status: UNKNOWN ·Phase: PHASE2
-
Pulmonary Hypertension and Imatinib
NCT01092897 ·Status: COMPLETED